395 related articles for article (PubMed ID: 30874446)
1. The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target.
Koga T; Ichinose K; Kawakami A; Tsokos GC
Expert Rev Clin Immunol; 2019 Jun; 15(6):629-637. PubMed ID: 30874446
[TBL] [Abstract][Full Text] [Related]
2. Current Insights and Future Prospects for Targeting IL-17 to Treat Patients With Systemic Lupus Erythematosus.
Koga T; Ichinose K; Kawakami A; Tsokos GC
Front Immunol; 2020; 11():624971. PubMed ID: 33597953
[TBL] [Abstract][Full Text] [Related]
3. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
Mardani F; Mahmoudi M; Esmaeili SA; Khorasani S; Tabasi N; Rastin M
J Cell Physiol; 2018 Jan; 234(1):642-649. PubMed ID: 30078223
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
[TBL] [Abstract][Full Text] [Related]
5. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
AlFadhli S; AlFailakawi A; Ghanem AA
Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17 and lupus: enough to be a target? For which patients?
Robert M; Miossec P
Lupus; 2020 Jan; 29(1):6-14. PubMed ID: 31791181
[TBL] [Abstract][Full Text] [Related]
7. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
8. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.
Dolff S; Quandt D; Wilde B; Feldkamp T; Hua F; Cai X; Specker C; Kribben A; Kallenberg CG; Witzke O
Arthritis Res Ther; 2010; 12(4):R150. PubMed ID: 20653937
[TBL] [Abstract][Full Text] [Related]
10. The star target in SLE: IL-17.
Yang Y; Yan C; Yu L; Zhang X; Shang J; Fan J; Zhang R; Ren J; Duan X
Inflamm Res; 2023 Feb; 72(2):313-328. PubMed ID: 36538077
[TBL] [Abstract][Full Text] [Related]
11. IL-12 and IL-23/Th17 axis in systemic lupus erythematosus.
Larosa M; Zen M; Gatto M; Jesus D; Zanatta E; Iaccarino L; Inês L; Doria A
Exp Biol Med (Maywood); 2019 Jan; 244(1):42-51. PubMed ID: 30664357
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of microRNA-873 facilitates Th17 differentiation by targeting forkhead box O1 (Foxo1) in the pathogenesis of systemic lupus erythematosus.
Liu L; Liu Y; Yuan M; Xu L; Sun H
Biochem Biophys Res Commun; 2017 Oct; 492(3):453-460. PubMed ID: 28837808
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.
Martin JC; Baeten DL; Josien R
Clin Immunol; 2014 Sep; 154(1):1-12. PubMed ID: 24858580
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus.
Szmyrka-Kaczmarek M; Kosmaczewska A; Ciszak L; Szteblich A; Wiland P
Postepy Hig Med Dosw (Online); 2014; 68():893-8. PubMed ID: 24988609
[TBL] [Abstract][Full Text] [Related]
15. Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells.
Shin MS; Lee N; Kang I
Curr Opin Rheumatol; 2011 Sep; 23(5):444-8. PubMed ID: 21720245
[TBL] [Abstract][Full Text] [Related]
16. IL-17 promotes murine lupus.
Amarilyo G; Lourenço EV; Shi FD; La Cava A
J Immunol; 2014 Jul; 193(2):540-3. PubMed ID: 24920843
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus.
Yang J; Yang X; Yang J; Li M
J Rheumatol; 2018 Jun; 45(6):818-826. PubMed ID: 29545450
[TBL] [Abstract][Full Text] [Related]
18. Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus.
Yang J; Yang X; Zou H; Chu Y; Li M
Rheumatology (Oxford); 2011 Aug; 50(8):1366-72. PubMed ID: 21489974
[TBL] [Abstract][Full Text] [Related]
19. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
[TBL] [Abstract][Full Text] [Related]
20. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
